These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8000 related articles for article (PubMed ID: 1623212)

  • 1. Effects of the Ru(III) complexes [mer-RuCl3(DMSO)2Im]degrees and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors.
    Sava G; Pacor S; Mestroni G; Alessio E
    Anticancer Drugs; 1992 Feb; 3(1):25-31. PubMed ID: 1623212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties.
    Sava G; Pacor S; Mestroni G; Alessio E
    Clin Exp Metastasis; 1992 Jul; 10(4):273-80. PubMed ID: 1617835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
    J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumors.
    Sava G; Clerici K; Capozzi I; Cocchietto M; Gagliardi R; Alessio E; Mestroni G; Perbellini A
    Anticancer Drugs; 1999 Jan; 10(1):129-38. PubMed ID: 10194556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.
    Sava G; Capozzi I; Clerici K; Gagliardi G; Alessio E; Mestroni G
    Clin Exp Metastasis; 1998 May; 16(4):371-9. PubMed ID: 9626816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition.
    Sava G; Pacor S; Bergamo A; Cocchietto M; Mestroni G; Alessio E
    Chem Biol Interact; 1995 Mar; 95(1-2):109-26. PubMed ID: 7697744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse.
    Gagliardi R; Sava G; Pacor S; Mestroni G; Alessio E
    Clin Exp Metastasis; 1994 Mar; 12(2):93-100. PubMed ID: 8306532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of residual metastases with Na[trans-RuCl4 (DMSO)lm] and ruthenium uptake by tumor cells.
    Bergamo A; Cocchietto M; Capozzi I; Mestroni G; Alessio E; Sava G
    Anticancer Drugs; 1996 Aug; 7(6):697-702. PubMed ID: 8913439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
    Bergamo A; Stocco G; Casarsa C; Cocchietto M; Alessio E; Serli B; Zorzet S; Sava G
    Int J Oncol; 2004 Feb; 24(2):373-9. PubMed ID: 14719114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice.
    Sava G; Gagliardi R; Cocchietto M; Clerici K; Capozzi I; Marrella M; Alessio E; Mestroni G; Milanino R
    Pathol Oncol Res; 1998; 4(1):30-6. PubMed ID: 9555118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4].
    Pacor S; Sava G; Ceschia V; Bregant F; Mestroni G; Alessio E
    Chem Biol Interact; 1991; 78(2):223-34. PubMed ID: 2040026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.
    Capozzi I; Clerici K; Cocchietto M; Salerno G; Bergamo A; Sava G
    Chem Biol Interact; 1998 May; 113(1):51-64. PubMed ID: 9630847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex.
    Sava G; Capozzi I; Bergamo A; Gagliardi R; Cocchietto M; Masiero L; Onisto M; Alessio E; Mestroni G; Garbisa S
    Int J Cancer; 1996 Sep; 68(1):60-6. PubMed ID: 8895542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[[trans-RuCl4(Me2SO)]2(mu-L)] (L = ditopic, non-chelating aromatic N-ligand). A preliminary investigation.
    Alessio E; Iengo E; Zorzet S; Bergamo A; Coluccia M; Boccarelli A; Sava G
    J Inorg Biochem; 2000 Apr; 79(1-4):173-7. PubMed ID: 10830863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
    Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G
    J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms.
    Sava G; Zorzet S; Giraldi T; Mestroni G; Zassinovich G
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):841-7. PubMed ID: 6540184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and X-ray Structural Analysis of the Ruthenium(III) Complex Na[trans-RuCl4(DMSO) (PyrDiaz)], the Diazene Derivative of Antitumor NAMI-Pyr.
    Vajs J; Pevec A; Gazvoda M; Urankar D; Goreshnik E; Polanc S; Košmrlj J
    Acta Chim Slov; 2017 Dec; 64(4):763-770. PubMed ID: 29318318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
    J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation.
    Griffith D; Cecco S; Zangrando E; Bergamo A; Sava G; Marmion CJ
    J Biol Inorg Chem; 2008 May; 13(4):511-20. PubMed ID: 18183430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
    Bergamo A; Gava B; Alessio E; Mestroni G; Serli B; Cocchietto M; Zorzet S; Sava G
    Int J Oncol; 2002 Dec; 21(6):1331-8. PubMed ID: 12429985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 400.